Skip to main content

This Stock Could Double by the End of the COVID-19 Pandemic

In China , Spain, Italy, and across the world, we've seen how quickly and easily medical systems can be swamped by big surges in novel coronavirus cases. In most places here in the United States, healthcare systems have borne up pretty well, though at times, they've been under punishing pressure. Officials have had to scramble to keep up with demand for care. Among other things, we've seen hotels in New York City pressed into service as hospitals and dormitories for healthcare providers. In Baltimore, the downtown convention center has become a hospital and testing center. In Bayou Segnette State Park, south of New Orleans, even recreational cabins were used as makeshift isolation wards. That's just some of the improvisation that's had to take place across virtually the entire country. Technological and medial improvisation has been a recurring theme in some of our talks about the national COVID-19 response. So today, I want to tell you about a company working to ease the need for such drastic measures. It's not working on a breakthrough vaccine or therapy, or on a lifesaving machine - though its work, in my view, is every bit as important to the fight. Rather, this company is working on a more, shall we say, basic, foundational approach. And it has a "secret weapon" that can not only help us beat the disease, but has applications and growth potential far beyond healthcare. Here's what they're up to... Full Story The post This Stock Could Double by the End of the COVID-19 Pandemic appeared first on Money Morning - We Make Investing Profitable . Here's what they're up to... Tags: Technology Article To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.